Company: SHPH
Filing Date: 2025-03-31
Form Type: DEF 14A
Source: 0001641172-25-001889
Chunk: 39

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-31
Form: DEF 14A
Chunk 39
---
-------:|:----|:--------------------------------------------|-------:|
| Mira Jung1      |     |        | 5/1/23  |     |                                                              | - |     |                                                                | - |     |                    | - |     |                 | - |     |                                                 |  1,194 |     | $                                           |  1,026 |
| Timothy Lorber2 |     |        | 6/13/24 |     |                                                              | - |     |                                                                | - |     |                    | - |     |                 | - |     |                                                 | 28,455 |     | $                                           | 24,443 |

| (1) | These                                                                                   
 restricted stock units vest in two installments on the anniversary of the grant date.   |
| (2) | These                                                                                   
 restricted stock units vest in three installments on the anniversary of the grant date. |

Each of our executive officers has entered into an employment agreement with us. The employees each will receive compensation on an annual basis in cash, payable in monthly installments commencing at the completion of our IPO, as well as restricted stock units (“RSUs”) subject to achieving certain key performance indicators. Certain of our executive officers are entitled to various target bonuses, upon achievement of certain milestones. The terms of the employment agreements are as follows:

Questions and Answers About the Meeting

Why am I receiving these materials?

You are receiving these materials because you were astockholder of Shuttle Pharmaceuticals Holdings, Inc. (the “Company”) as of March 13, 2025, which is the Record Date of our 2025 Annual Meeting of Stockholders. Our 2025 Annual Meeting of Stockholders will be held virtually on Friday, May 9, 2025 at www.virtualshareholdermeeting.com/SHPH2025.

What proposals will be voted on at the Annual Meeting and how does the Board of Directors recommend that i vote?

| PROPOSAL                                                                                                                           
 1: ELECTION OF DIRECTORS                                                                                                           |
| The                                                                                                                                
 Board of Directors recommends that you vote FOR each director nominee. These individuals bring a range of relevant experiences and 
 overall diversity of perspectives that is essential to good governance and leadership of our Company.                              |

| PROPOSAL                                                                                                                     
 3: EXECUTIVE COMPENSATION                                                                                                    |
| The                                                                                                                          
 Board of Directors recommends that you vote FOR approval of the Company’s executive compensation plan, on an advisory basis. 
 We believe the numbers that we have